» Articles » PMID: 39095825

An Overview of the Application and Potential Mechanism on the Triglyceride Glucose Index with Multi-vessel Coronary Disease

Overview
Publisher Biomed Central
Date 2024 Aug 2
PMID 39095825
Authors
Affiliations
Soon will be listed here.
Abstract

Multi-vessel coronary disease (MVCD) is a severe form of coronary artery disease (CAD) that significantly increases the risk of acute coronary syndrome (ACS) and heart attacks. The triglyceride glucose (TyG) index is a reliable and convenient marker for insulin resistance (IR). Recent studies have demonstrated its predictive value for CAD in patients with MVCD. This review aims to explore the application of the TyG index in managing MVCD and its underlying pathogenesis to enhance risk stratification and improve therapeutic decision-making.

References
1.
Krishnan R, Sekar D, Karunanithy S, Subramanium S . Association of angiotensin converting enzyme gene insertion/deletion polymorphism with essential hypertension in south Indian population. Genes Dis. 2018; 3(2):159-163. PMC: 6146176. DOI: 10.1016/j.gendis.2016.03.001. View

2.
Cui H, Liu Q, Wu Y, Cao L . Cumulative triglyceride-glucose index is a risk for CVD: a prospective cohort study. Cardiovasc Diabetol. 2022; 21(1):22. PMC: 8830002. DOI: 10.1186/s12933-022-01456-1. View

3.
Obisesan O, Kou M, Wang F, Boakye E, Honda Y, Uddin S . Lipoprotein(a) and Subclinical Vascular and Valvular Calcification on Cardiac Computed Tomography: The Atherosclerosis Risk in Communities Study. J Am Heart Assoc. 2022; 11(11):e024870. PMC: 9238743. DOI: 10.1161/JAHA.121.024870. View

4.
Zhu Y, Liu K, Chen M, Liu Y, Gao A, Hu C . Triglyceride-glucose index is associated with in-stent restenosis in patients with acute coronary syndrome after percutaneous coronary intervention with drug-eluting stents. Cardiovasc Diabetol. 2021; 20(1):137. PMC: 8268452. DOI: 10.1186/s12933-021-01332-4. View

5.
Gao J, Wang Y, Yang Y, Wu X, Cui Y, Zou Z . Impact of Metabolic Syndrome and Its Components on Clinical Severity and Long-Term Prognosis in Patients With Premature Myocardial Infarction. Front Endocrinol (Lausanne). 2022; 13:920470. PMC: 9279730. DOI: 10.3389/fendo.2022.920470. View